 | • レポートコード：MRC2312MG12745 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のアデノ随伴ウイルス遺伝子治療市場規模と予測を収録しています。・世界のアデノ随伴ウイルス遺伝子治療市場：売上、2018年-2023年、2024年-2029年 ・世界のアデノ随伴ウイルス遺伝子治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のアデノ随伴ウイルス遺伝子治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「遺伝子サイレンシング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 アデノ随伴ウイルス遺伝子治療のグローバル主要企業は、Creative Biolabs、 Affinia Therapeutics、 Spark Therapeutics、 AGC Biologics、 StrideBio、 SIRION Biotech、 Neurophth Biotechnology、 Belief BioMed、 BiBo Biopharma Engineering Co., Ltd.、 Beihai Kangcheng、 PackGene Biotech、 Sarepta Therapeutics、 Carbon BioSciences、 Kelonia Therapeutics、 Roche、 Remedium Bioなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、アデノ随伴ウイルス遺伝子治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のアデノ随伴ウイルス遺伝子治療市場：タイプ別、2018年-2023年、2024年-2029年 世界のアデノ随伴ウイルス遺伝子治療市場：タイプ別市場シェア、2022年 ・遺伝子サイレンシング、遺伝子置換、遺伝子追加、遺伝子編集 世界のアデノ随伴ウイルス遺伝子治療市場：用途別、2018年-2023年、2024年-2029年 世界のアデノ随伴ウイルス遺伝子治療市場：用途別市場シェア、2022年 ・病院、研究所、その他 世界のアデノ随伴ウイルス遺伝子治療市場：地域・国別、2018年-2023年、2024年-2029年 世界のアデノ随伴ウイルス遺伝子治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるアデノ随伴ウイルス遺伝子治療のグローバル売上、2018年-2023年 ・主要企業におけるアデノ随伴ウイルス遺伝子治療のグローバル売上シェア、2022年 ・主要企業におけるアデノ随伴ウイルス遺伝子治療のグローバル販売量、2018年-2023年 ・主要企業におけるアデノ随伴ウイルス遺伝子治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Creative Biolabs、 Affinia Therapeutics、 Spark Therapeutics、 AGC Biologics、 StrideBio、 SIRION Biotech、 Neurophth Biotechnology、 Belief BioMed、 BiBo Biopharma Engineering Co., Ltd.、 Beihai Kangcheng、 PackGene Biotech、 Sarepta Therapeutics、 Carbon BioSciences、 Kelonia Therapeutics、 Roche、 Remedium Bio ************************************************************* ・調査・分析レポートの概要 アデノ随伴ウイルス遺伝子治療市場の定義 市場セグメント 世界のアデノ随伴ウイルス遺伝子治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のアデノ随伴ウイルス遺伝子治療市場規模 世界のアデノ随伴ウイルス遺伝子治療市場規模：2022年 VS 2029年 世界のアデノ随伴ウイルス遺伝子治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのアデノ随伴ウイルス遺伝子治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のアデノ随伴ウイルス遺伝子治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：遺伝子サイレンシング、遺伝子置換、遺伝子追加、遺伝子編集 アデノ随伴ウイルス遺伝子治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所、その他 アデノ随伴ウイルス遺伝子治療の用途別グローバル売上・予測 ・地域別市場分析 地域別アデノ随伴ウイルス遺伝子治療市場規模 2022年と2029年 地域別アデノ随伴ウイルス遺伝子治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Creative Biolabs、 Affinia Therapeutics、 Spark Therapeutics、 AGC Biologics、 StrideBio、 SIRION Biotech、 Neurophth Biotechnology、 Belief BioMed、 BiBo Biopharma Engineering Co., Ltd.、 Beihai Kangcheng、 PackGene Biotech、 Sarepta Therapeutics、 Carbon BioSciences、 Kelonia Therapeutics、 Roche、 Remedium Bio ... |
This research report provides a comprehensive analysis of the Adeno-Associated Virus Gene Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Adeno-Associated Virus Gene Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Adeno-Associated Virus Gene Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Adeno-Associated Virus Gene Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Adeno-Associated Virus Gene Therapy market presents opportunities for various stakeholders, including Hospitals, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Adeno-Associated Virus Gene Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Adeno-Associated Virus Gene Therapy market was valued at US$ 1414.8 million in 2022 and is projected to reach US$ 2399.6 million by 2029, at a CAGR of 7.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Adeno-Associated Virus Gene Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Adeno-Associated Virus Gene Therapy market.
Market Overview: The report provides a comprehensive overview of the Adeno-Associated Virus Gene Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Gene Silencing, Gene Replacement), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Adeno-Associated Virus Gene Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Adeno-Associated Virus Gene Therapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Adeno-Associated Virus Gene Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Adeno-Associated Virus Gene Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Adeno-Associated Virus Gene Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Adeno-Associated Virus Gene Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Adeno-Associated Virus Gene Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Adeno-Associated Virus Gene Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Adeno-Associated Virus Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gene Silencing
Gene Replacement
Gene Addition
Gene Editing
Market segment by Application
Hospitals
Research Institute
Others
Global Adeno-Associated Virus Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adeno-Associated Virus Gene Therapy, market overview.
Chapter 2: Global Adeno-Associated Virus Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Adeno-Associated Virus Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adeno-Associated Virus Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Adeno-Associated Virus Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adeno-Associated Virus Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adeno-Associated Virus Gene Therapy Overall Market Size
2.1 Global Adeno-Associated Virus Gene Therapy Market Size: 2022 VS 2029
2.2 Global Adeno-Associated Virus Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adeno-Associated Virus Gene Therapy Players in Global Market
3.2 Top Global Adeno-Associated Virus Gene Therapy Companies Ranked by Revenue
3.3 Global Adeno-Associated Virus Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adeno-Associated Virus Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adeno-Associated Virus Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adeno-Associated Virus Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adeno-Associated Virus Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adeno-Associated Virus Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Adeno-Associated Virus Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Gene Silencing
4.1.3 Gene Replacement
4.1.4 Gene Addition
4.1.5 Gene Editing
4.2 By Type – Global Adeno-Associated Virus Gene Therapy Revenue & Forecasts
4.2.1 By Type – Global Adeno-Associated Virus Gene Therapy Revenue, 2018-2023
4.2.2 By Type – Global Adeno-Associated Virus Gene Therapy Revenue, 2024-2029
4.2.3 By Type – Global Adeno-Associated Virus Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adeno-Associated Virus Gene Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research Institute
5.1.4 Others
5.2 By Application – Global Adeno-Associated Virus Gene Therapy Revenue & Forecasts
5.2.1 By Application – Global Adeno-Associated Virus Gene Therapy Revenue, 2018-2023
5.2.2 By Application – Global Adeno-Associated Virus Gene Therapy Revenue, 2024-2029
5.2.3 By Application – Global Adeno-Associated Virus Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Adeno-Associated Virus Gene Therapy Market Size, 2022 & 2029
6.2 By Region – Global Adeno-Associated Virus Gene Therapy Revenue & Forecasts
6.2.1 By Region – Global Adeno-Associated Virus Gene Therapy Revenue, 2018-2023
6.2.2 By Region – Global Adeno-Associated Virus Gene Therapy Revenue, 2024-2029
6.2.3 By Region – Global Adeno-Associated Virus Gene Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Adeno-Associated Virus Gene Therapy Revenue, 2018-2029
6.3.2 US Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.3.3 Canada Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.3.4 Mexico Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Adeno-Associated Virus Gene Therapy Revenue, 2018-2029
6.4.2 Germany Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.3 France Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.4 U.K. Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.5 Italy Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.6 Russia Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.4.8 Benelux Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Adeno-Associated Virus Gene Therapy Revenue, 2018-2029
6.5.2 China Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.5.3 Japan Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.5.4 South Korea Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.5.6 India Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Adeno-Associated Virus Gene Therapy Revenue, 2018-2029
6.6.2 Brazil Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.6.3 Argentina Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Adeno-Associated Virus Gene Therapy Revenue, 2018-2029
6.7.2 Turkey Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.7.3 Israel Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
6.7.5 UAE Adeno-Associated Virus Gene Therapy Market Size, 2018-2029
7 Adeno-Associated Virus Gene Therapy Companies Profiles
7.1 Creative Biolabs
7.1.1 Creative Biolabs Company Summary
7.1.2 Creative Biolabs Business Overview
7.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Major Product Offerings
7.1.4 Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Creative Biolabs Key News & Latest Developments
7.2 Affinia Therapeutics
7.2.1 Affinia Therapeutics Company Summary
7.2.2 Affinia Therapeutics Business Overview
7.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Major Product Offerings
7.2.4 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Affinia Therapeutics Key News & Latest Developments
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Company Summary
7.3.2 Spark Therapeutics Business Overview
7.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Major Product Offerings
7.3.4 Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Spark Therapeutics Key News & Latest Developments
7.4 AGC Biologics
7.4.1 AGC Biologics Company Summary
7.4.2 AGC Biologics Business Overview
7.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Major Product Offerings
7.4.4 AGC Biologics Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 AGC Biologics Key News & Latest Developments
7.5 StrideBio
7.5.1 StrideBio Company Summary
7.5.2 StrideBio Business Overview
7.5.3 StrideBio Adeno-Associated Virus Gene Therapy Major Product Offerings
7.5.4 StrideBio Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 StrideBio Key News & Latest Developments
7.6 SIRION Biotech
7.6.1 SIRION Biotech Company Summary
7.6.2 SIRION Biotech Business Overview
7.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Major Product Offerings
7.6.4 SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 SIRION Biotech Key News & Latest Developments
7.7 Neurophth Biotechnology
7.7.1 Neurophth Biotechnology Company Summary
7.7.2 Neurophth Biotechnology Business Overview
7.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Major Product Offerings
7.7.4 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Neurophth Biotechnology Key News & Latest Developments
7.8 Belief BioMed
7.8.1 Belief BioMed Company Summary
7.8.2 Belief BioMed Business Overview
7.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Major Product Offerings
7.8.4 Belief BioMed Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Belief BioMed Key News & Latest Developments
7.9 BiBo Biopharma Engineering Co., Ltd.
7.9.1 BiBo Biopharma Engineering Co., Ltd. Company Summary
7.9.2 BiBo Biopharma Engineering Co., Ltd. Business Overview
7.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Major Product Offerings
7.9.4 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 BiBo Biopharma Engineering Co., Ltd. Key News & Latest Developments
7.10 Beihai Kangcheng
7.10.1 Beihai Kangcheng Company Summary
7.10.2 Beihai Kangcheng Business Overview
7.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Major Product Offerings
7.10.4 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Beihai Kangcheng Key News & Latest Developments
7.11 PackGene Biotech
7.11.1 PackGene Biotech Company Summary
7.11.2 PackGene Biotech Business Overview
7.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Major Product Offerings
7.11.4 PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 PackGene Biotech Key News & Latest Developments
7.12 Sarepta Therapeutics
7.12.1 Sarepta Therapeutics Company Summary
7.12.2 Sarepta Therapeutics Business Overview
7.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Major Product Offerings
7.12.4 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 Sarepta Therapeutics Key News & Latest Developments
7.13 Carbon BioSciences
7.13.1 Carbon BioSciences Company Summary
7.13.2 Carbon BioSciences Business Overview
7.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Major Product Offerings
7.13.4 Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 Carbon BioSciences Key News & Latest Developments
7.14 Kelonia Therapeutics
7.14.1 Kelonia Therapeutics Company Summary
7.14.2 Kelonia Therapeutics Business Overview
7.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Major Product Offerings
7.14.4 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Kelonia Therapeutics Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Adeno-Associated Virus Gene Therapy Major Product Offerings
7.15.4 Roche Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Remedium Bio
7.16.1 Remedium Bio Company Summary
7.16.2 Remedium Bio Business Overview
7.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Major Product Offerings
7.16.4 Remedium Bio Adeno-Associated Virus Gene Therapy Revenue in Global Market (2018-2023)
7.16.5 Remedium Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
